3DBIO Trademark

Trademark Overview

On Monday, March 5, 2018, a trademark application was filed for 3DBIO with the United States Patent and Trademark Office. The USPTO has given the 3DBIO trademark a serial number of 87820555. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by Vivax Bio, LLC. The 3DBIO trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus for the fabrication of biological tissues, tissue arrays, organ constructs, organoids, and organs, namely, artificial biomaterials for use in the augmentation of bone and tissue for medical purposes; surgical implants comprising artificial material
3dbio

General Information

Serial Number87820555
Word Mark3DBIO
Filing DateMonday, March 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized wording "3DBIO" comprised of full and partial circles.
Pseudo MarkTHREE D BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical apparatus for the fabrication of biological tissues, tissue arrays, organ constructs, organoids, and organs, namely, artificial biomaterials for use in the augmentation of bone and tissue for medical purposes; surgical implants comprising artificial material

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivax Bio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10031
Party NameVivax Bio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10031

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2022SOU EXTENSION 2 GRANTED
Friday, February 25, 2022SOU EXTENSION 2 FILED
Friday, February 25, 2022TEAS EXTENSION RECEIVED
Saturday, July 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 8, 2021SOU EXTENSION 1 GRANTED
Thursday, July 8, 2021SOU EXTENSION 1 FILED
Thursday, July 8, 2021TEAS EXTENSION RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 7, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 11, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 10, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 9, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 9, 2019LETTER OF SUSPENSION E-MAILED
Friday, August 9, 2019SUSPENSION LETTER WRITTEN
Friday, August 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2019NON-FINAL ACTION WRITTEN
Monday, February 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 6, 2018NON-FINAL ACTION E-MAILED
Thursday, December 6, 2018NON-FINAL ACTION WRITTEN
Monday, December 3, 2018ASSIGNED TO EXAMINER
Tuesday, November 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 20, 2018ASSIGNED TO LIE
Wednesday, November 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2018NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2018NON-FINAL ACTION WRITTEN
Saturday, June 16, 2018ASSIGNED TO EXAMINER
Saturday, March 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 8, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dbio medical artificial tissue augmentation biomaterials material bone purposes surgical comprising